Filing Details
- Accession Number:
- 0001567619-22-022055
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-28 08:22:56
- Reporting Period:
- 2022-12-23
- Accepted Time:
- 2022-12-28 08:22:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1505497 | Biorestorative Therapies Inc. | BRTX | Services-Misc Health & Allied Services, Nec (8090) | 911835664 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1756228 | Lance Alstodt | C/O Biorestorative Therapies, Inc. 40 Marcus Drive, Suite 1 Melville NY 11747 | President, Ceo, Cob | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-12-23 | 200 | $3.02 | 185,921 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-12-23 | 100 | $2.99 | 186,021 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | $5.08 | 2031-03-18 | 293,479 | 293,479 | Direct | |
Common Stock | Stock Option | $5.08 | 2031-11-04 | 42,059 | 42,059 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2031-03-18 | 293,479 | 293,479 | Direct |
2031-11-04 | 42,059 | 42,059 | Direct |
Footnotes
- Includes 100,935 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,036 shares on January 18, 2023, 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024.
- The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 with the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested.
- The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022.